# FDA 483 - Altaire Pharmaceuticals, Inc. - March 09, 2017

Source: https://www.keypedia.com/records/483/altaire-pharmaceuticals-inc/6f5a38e3-831e-43d0-8235-9fde10683ff0

> FDA 483 for Altaire Pharmaceuticals, Inc. on March 09, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Altaire Pharmaceuticals, Inc.
- Inspection Date: 2017-03-09
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: An FDA inspection of Altaire Pharmaceuticals, Inc., a sterile ophthalmic manufacturer in Aquebogue, NY, revealed significant deficiencies across multiple areas. Observations included failures in aseptic manufacturing procedures, incomplete laboratory records, inadequate laboratory controls for microbial testing and environmental monitoring, and a lack of validated manufacturing processes. Additionally, the firm's complaint handling procedures were found to be deficient, lacking proper review and trending analysis.

## Related Documents

- [483 - 2019-04-19](https://www.keypedia.com/records/483/altaire-pharmaceuticals-inc/17b1c45d-8f0f-4d45-b23c-7c3a31908c74)
- [WARNING_LETTER - 2019-04-19](https://www.keypedia.com/records/warning_letter/altaire-pharmaceuticals-inc/ee7eb9fc-d9b3-4f35-a5bd-d29200e5854a)
- [483 - 2022-02-11](https://www.keypedia.com/records/483/altaire-pharmaceuticals-inc/d46bc047-8578-43cb-be2b-15ad8354c610)

## Related Officers

- [Biotechnology Specialist at FDA](https://www.keypedia.com/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd)

Company: https://www.keypedia.com/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961